Oral and Maxillofacial Surgery
Appropriate surgical margin for odontogenic myxoma: a review of 12 cases

https://doi.org/10.1016/j.oooo.2018.06.002Get rights and content

Objective

Odontogenic myxoma (OM) is a rare benign tumor that is frequently nonencapsulated and invades the surrounding bone, resulting in a high risk of recurrence. However, the optimal surgical technique and appropriate surgical margin remains controversial. Here, we report our clinical investigation of 12 patients with OM diagnosed histopathologically.

Study Design

We retrospectively reviewed the records of 12 patients treated at our institution. Osteotomy or bone shaving with enucleation was generally performed with 5-mm bony margins from the radiologic extent of the tumor.

Results

One half of the cases occurred in the maxilla and the other half in the mandible. Treatment for maxillary OM was enucleation in 2 patients and maxillectomy in 4 patients. Treatment for mandibular OM was enucleation with shaving of the surrounding bone in 1 patient and segmental mandibulectomy in 5 patients. Radiographs of surgical specimen removed by segmental mandibulectomy indicated that the mean distance between the tumor and the margin was 5.4 (range 3.4–7.0) mm. Tumor recurrence was noted in 1 patient who had undergone enucleation alone.

Conclusion

The 1-cm surgical margin for OM, as reported conventionally, might not be necessary. A prospective study is needed to determine the appropriate surgical margin for OM.

Section snippets

MATERIAL AND METHODS

We retrospectively reviewed the records of 12 patients with a histologic diagnosis of OM treated at the Department of Oral and Maxillofacial Surgery, Tokyo Medical and Dental University, between April 2001 and March 2015. Clinical, radiologic, and histopathologic findings, treatment provided, and clinical course of these patients were evaluated. Osteotomy or bone shaving with enucleation was performed with 5-mm bony margins from the radiologic extent of the tumor based on the report that a 1-cm

Clinical characteristics

Six hundred and thirty-four patients with histopathologically diagnosed odontogenic tumors were treated at our institution during the study period. OM accounted for 1.9% of all cases of odontogenic tumors treated during this time. OM cases comprised 4 men and 8 women with a median age of 41.5 (range 27–65) years at the first visit (Table 1). These patients presented from 1 month to 10 years (median 2.5 years) after they first noticed symptoms or after the lesion had been identified at another

DISCUSSION

OM is a rare benign but locally aggressive tumor of the jaw. This tumor has been reported to account for 0.5–20% of all odontogenic tumors in adults and 8.5–11.6% of those in children.1 There seems to be a regional difference in prevalence, in that OM is more common in African and Caucasian populations than in the population of the Far East.5 In this report, we describe 12 cases (1.9%) of OM out of 634 odontogenic tumors treated at our department over a period of 14 years.

Some studies have

REFERENCES (12)

There are more references available in the full text version of this article.

Cited by (15)

  • Surgical management of odontogenic myxomas: A case series

    2023, International Journal of Surgery Case Reports
  • A case of dentinogenic ghost cell tumor of the mandible with a review of the literature

    2023, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
  • Odontogenic myxoma of the maxilla: A rare case report and review of the literature

    2022, Annals of Medicine and Surgery
    Citation Excerpt :

    Radical surgical resection includes a 1.5–2 cm of healthy bone margin, to reduce the risk of recurrence [7]. Some authors, however, have suggested that a margin of healthy bone tissue might not be necessary to avoid recurrence [30]. Conservative treatment by enucleation and curettage is recommended for tumors with a diameter less than 3 cm, but since myxomas are not encapsulated and tend to infiltrate the surrounding bone, a more extensive resection than curettage and peripheral osteotomy is often required for larger lesions [6,8,10].

  • Conservative surgical treatment of odontogenic myxoma with preservation of the inferior alveolar nerve

    2022, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
    Citation Excerpt :

    Several reports recommend radical methods that ensure a safety margin of ≥1 cm around the tumor [3,6,10,14,15]. In our previous clinical investigation of patients with OM, we observed a mean distance of 5.4 mm (range, 3.4–7.0 mm) between the tumor and the bone margin using radiographs of surgical specimen in segmental mandibulectomy cases; notably, no recurrent cases were observed [16]. Therefore, we reported that the conventional safety margin of ≥1 cm for OM, a benign tumor, might not be necessary.

  • Navigation-assisted transoral resection of a large maxillary odontogenic myxofibroma using rigid endoscopy

    2020, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
    Citation Excerpt :

    Clinically, odontogenic myxoma is characterized by slow growth and bony invasion, resulting in a painless facial deformity [3,8–10]. Although the only treatment available for odontogenic myxoma is surgery, there is no consensus regarding the best surgical technique for odontogenic myxoma [8,9,11,12]. This report describes the case of a 36-year-old man with a maxillary odontogenic myxofibroma that was resected transorally by navigation-assisted surgery and by using a rigid endoscopy and discusses the usefulness of this system for the surgery of maxillary benign tumors.

  • Primordial odontogenic tumour: A systematic review of the common but also unusual features of this novel entity

    2020, Journal of Stomatology, Oral and Maxillofacial Surgery
    Citation Excerpt :

    The aim of this systematic review is to update all available data on POT published in the literature and to identify those features of the neoplasm that require further investigation in future studies. It is fundamental that clinicians worldwide increase their awareness of the existence of this neoplasm in the pediatric population since it can be surgically enucleated without the use of more aggressive approaches, such as those required for ameloblastoma or odontogenic myxoma [8,9]. This study followed the guidelines of the PRISMA statement [10].

View all citing articles on Scopus

Declarations of interest: none

View full text